17.4K
Downloads
65
Episodes
IPA’s What, Why & How podcast unravels the intricacies of pharmacy and healthcare law and regulation, from Congress to the Board of Pharmacy. Each month, IPA’s CEO, Kate Gainer, welcomes a special guest to explore WHAT changes occurred, WHY action was taken, and HOW these changes will impact pharmacy practice.
Episodes
May 5, 2022
May 5, 2022
16 min
Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.
No comments yet. Be the first to say something!